Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $45.42 which represents a slight increase of $0.79 or 1.77% from the prior close of $44.63. The stock opened at $45.17 and ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

Tandem Diabetes Care, Inc.’s TNDM flagship t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) technology is now certified for use with Eli Lilly and Company’s LLY Lyumjev (insulin ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Capital World Investors (Trades, Portfolio) executed a significant transaction by reducing their holdings in Tandem Diabetes ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

An investigational once-weekly insulin was noninferior to a daily option for patients with type 2 diabetes, but proved risky ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Researchers in China examined middle-aged male monkeys and found that those given a daily dose of metformin over three years ...

Diabetes can worsen the state of your gums, but a new study suggests that diabetes medications may undo some of that ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...